Shopping Cart 0
Cart Subtotal
USD 0

Piramal Enterprises Ltd (PEL) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd (PEL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Piramal Enterprises Ltd, Medical Equipment, Deal Details 10

Asset Purchase 10

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11

Partnerships 12

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 12

Equity Offering 13

Piramal Enterprises Plans to Raise Funds through Public Offering 13

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 14

Debt Offering 15

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 15

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 16

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 17

Asset Transactions 18

Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 18

DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19

Acquisition 20

Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 21

Piramal Enterprises Ltd-Key Competitors 22

Piramal Enterprises Ltd-Key Employees 23

Piramal Enterprises Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 27

Financial Announcements 27

Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018 27

May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018 29

Corporate Communications 31

Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board 31

Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 32

Product News 33

Oct 05, 2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Piramal Enterprises Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Piramal Enterprises Ltd, Medical Equipment, Key Facts, 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Deals By Market, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 12

Piramal Enterprises Plans to Raise Funds through Public Offering 13

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 14

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 15

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 16

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 17

Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 18

DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19

Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 21

Piramal Enterprises Ltd, Key Competitors 22

Piramal Enterprises Ltd, Key Employees 23

Piramal Enterprises Ltd, Other Locations 24

Piramal Enterprises Ltd, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Piramal Enterprises Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd (PEL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Piramal Enterprises Ltd, Medical Equipment, Deal Details 10

Asset Purchase 10

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11

Partnerships 12

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 12

Equity Offering 13

Piramal Enterprises Plans to Raise Funds through Public Offering 13

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 14

Debt Offering 15

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 15

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 16

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 17

Asset Transactions 18

Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 18

DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19

Acquisition 20

Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 21

Piramal Enterprises Ltd-Key Competitors 22

Piramal Enterprises Ltd-Key Employees 23

Piramal Enterprises Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 27

Financial Announcements 27

Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018 27

May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018 29

Corporate Communications 31

Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board 31

Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 32

Product News 33

Oct 05, 2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Piramal Enterprises Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Piramal Enterprises Ltd, Medical Equipment, Key Facts, 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Deals By Market, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 12

Piramal Enterprises Plans to Raise Funds through Public Offering 13

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 14

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 15

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 16

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 17

Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 18

DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19

Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 21

Piramal Enterprises Ltd, Key Competitors 22

Piramal Enterprises Ltd, Key Employees 23

Piramal Enterprises Ltd, Other Locations 24

Piramal Enterprises Ltd, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Piramal Enterprises Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.